Murugaraj Jeyaraj
- Materials Chemistry top 5%
- Biomedical Engineering top 5%
- Biomaterials top 2%
- Molecular Biology
- Plant Science top 10%
- Co-authors
- Sivaraj MehnathGaneshan SivanandhanMarkandan ManickavasagamMariappan RajanGnanasekar SathishkumarArun RenganathanAndy GanapathiKumpati Premkumar
- Topics
- Nanoparticle-Based Drug Delivery (12 papers)Graphene and Nanomaterials Applications (10 papers)Nanoparticles: synthesis and applications (8 papers)
- Partner nations
- IndiaSaudi ArabiaFrance
In The Last Decade
Murugaraj Jeyaraj
45 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 108
- Materials Chemistry 812
- Biomedical Engineering 686
- Biomaterials 489
- Molecular Biology 473
- Plant Science 313
Countries citing papers authored by Murugaraj Jeyaraj
This map shows the geographic impact of Murugaraj Jeyaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murugaraj Jeyaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murugaraj Jeyaraj more than expected).
Fields of papers citing papers by Murugaraj Jeyaraj
This network shows the impact of papers produced by Murugaraj Jeyaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murugaraj Jeyaraj. The network helps show where Murugaraj Jeyaraj may publish in the future.
Co-authorship network of co-authors of Murugaraj Jeyaraj
This figure shows the co-authorship network connecting the top 25 collaborators of Murugaraj Jeyaraj. A scholar is included among the top collaborators of Murugaraj Jeyaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murugaraj Jeyaraj. Murugaraj Jeyaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 9 | |
| 4 | 32 | |
| 5 | 9 | |
| 6 | 15 | |
| 7 | 61 | |
| 8 | 29 | |
| 9 | 44 | |
| 10 | 40 | |
| 11 | 16 | |
| 12 | 44 | |
| 13 | 38 | |
| 14 | 33 | |
| 15 | 62 | |
| 16 | 21 | |
| 17 | 365 | |
| 18 | 82 | |
| 19 | 50 | |
| 20 | 10 |
About Murugaraj Jeyaraj
Murugaraj Jeyaraj is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Medicine, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Graphene and Nanomaterials Applications (10 papers) and Nanoparticles: synthesis and applications (8 papers). The work is most often cited by research in Drug Discovery (9 citations), Biomaterials (489 citations) and Complementary and alternative medicine (239 citations). Murugaraj Jeyaraj has collaborated with scholars based in India, Saudi Arabia and France. Frequent co-authors include Sivaraj Mehnath, Ganeshan Sivanandhan, Markandan Manickavasagam, Mariappan Rajan, Gnanasekar Sathishkumar, Arun Renganathan, Andy Ganapathi, Kumpati Premkumar, Davoodbasha MubarakAli and Nooruddin Thajuddin. Their work appears in journals such as ACS Applied Materials & Interfaces, Polymer and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.